Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of GBP 1.34 billion. The enterprise value is 7.49 billion.
| Market Cap | 1.34B |
| Enterprise Value | 7.49B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | Feb 23, 2026 |
Share Statistics
| Current Share Class | 260.32M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.62% |
| Shares Change (QoQ) | -0.18% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 77.00% |
| Float | 259.03M |
Valuation Ratios
The trailing PE ratio is 9.63 and the forward PE ratio is 1.99.
| PE Ratio | 9.63 |
| Forward PE | 1.99 |
| PS Ratio | 0.29 |
| PB Ratio | 2.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.35 |
| P/OCF Ratio | 2.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.81, with an EV/FCF ratio of 18.75.
| EV / Earnings | 53.94 |
| EV / Sales | 1.61 |
| EV / EBITDA | 5.81 |
| EV / EBIT | 7.75 |
| EV / FCF | 18.75 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 11.70.
| Current Ratio | 1.82 |
| Quick Ratio | 0.84 |
| Debt / Equity | 11.70 |
| Debt / EBITDA | 5.10 |
| Debt / FCF | 16.36 |
| Interest Coverage | 2.57 |
Financial Efficiency
Return on equity (ROE) is 30.56% and return on invested capital (ROIC) is 6.31%.
| Return on Equity (ROE) | 30.56% |
| Return on Assets (ROA) | 6.22% |
| Return on Invested Capital (ROIC) | 6.31% |
| Return on Capital Employed (ROCE) | 12.34% |
| Weighted Average Cost of Capital (WACC) | 3.32% |
| Revenue Per Employee | 461,849 |
| Profits Per Employee | 13,894 |
| Employee Count | 10,000 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.08 |
Taxes
In the past 12 months, Organon & Co. has paid 176.83 million in taxes.
| Income Tax | 176.83M |
| Effective Tax Rate | 56.00% |
Stock Price Statistics
The stock price has decreased by -52.14% in the last 52 weeks. The beta is 0.54, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -52.14% |
| 50-Day Moving Average | 7.94 |
| 200-Day Moving Average | 8.81 |
| Relative Strength Index (RSI) | 35.90 |
| Average Volume (20 Days) | 20,486 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.31 |
Income Statement
In the last 12 months, Organon & Co. had revenue of GBP 4.62 billion and earned 138.94 million in profits. Earnings per share was 0.53.
| Revenue | 4.62B |
| Gross Profit | 2.51B |
| Operating Income | 960.70M |
| Pretax Income | 315.78M |
| Net Income | 138.94M |
| EBITDA | 1.23B |
| EBIT | 960.70M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
The company has 426.48 million in cash and 6.54 billion in debt, with a net cash position of -6.11 billion.
| Cash & Cash Equivalents | 426.48M |
| Total Debt | 6.54B |
| Net Cash | -6.11B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 558.74M |
| Book Value Per Share | 2.15 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was 520.10 million and capital expenditures -120.37 million, giving a free cash flow of 399.73 million.
| Operating Cash Flow | 520.10M |
| Capital Expenditures | -120.37M |
| Free Cash Flow | 399.73M |
| FCF Per Share | n/a |
Margins
Gross margin is 54.34%, with operating and profit margins of 20.80% and 3.01%.
| Gross Margin | 54.34% |
| Operating Margin | 20.80% |
| Pretax Margin | 6.84% |
| Profit Margin | 3.01% |
| EBITDA Margin | 26.61% |
| EBIT Margin | 20.80% |
| FCF Margin | 8.66% |
Dividends & Yields
This stock pays an annual dividend of 0.06, which amounts to a dividend yield of 0.87%.
| Dividend Per Share | 0.06 |
| Dividend Yield | 0.87% |
| Dividend Growth (YoY) | -93.20% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 47.06% |
| Buyback Yield | -0.62% |
| Shareholder Yield | 0.24% |
| Earnings Yield | 10.38% |
| FCF Yield | 29.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.26 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 6 |